Successfully delivering, phase I to phase III, full service global clinical trials
Early Access Programs
Our Early Access Programs deliver potentially lifesaving treatments to patients around the world
Our mission is to deliver a unique, seamless approach to clinical research. Our partnership relationships are paramount to everything that we do and we work closely with our clients to become an extended part of their team. We understand that we are ultimately dealing with patients’ lives. This drives our philosophy to challenge the norm and bring new medicines to patients faster.
At Bionical Emas, everything we do is shaped by our three core values:
We develop projects with expertise, experience and veracity
We shape projects with established market knowledge
We build long term, mutually beneficial, partnerships
Bionical Emas holds the following licences and certifications (copies of licences and certifications are available upon request).
MHRA Certificate of GDP Compliance of a Wholesale Distributor
Wholesale Distribution Authorisation (Human) (WDA (H) 36296)
Manufacturer’s “Specials” Licence (MS 36296)
Home Office Controlled Drug License